Responsibilities: Clinical Trial Support • Develop, maintain, manage, and link relationships within investigational sites and across relevant referral networks to increase awareness of the clinical trial to maximize their success in reaching their enrollment goals; • Drive identification of potential sites and investigators for clinical trials; • In collaboration with the Clinical Development and Operations teams, support clinical study feasibility and effective study implementation; • Enhance clinical operations efforts to support and/or improve recruitment & retention by possible education, training, clinical discussions with clinical research/investigator’s team; • Support the development of patient referral network within the geographic area; • Identify effective prescreening strategies for each trial and recommend improvements; • Work with study team to develop, plan, and execute strategies that will increase enrollment at the clinical trial site level; • Support the Development CNS Center Of Excellence Map considering key criteria including KOLs/TLs, geographic footprint, referral network, capacity and infrastructure. External Engagement & Development • Establish a network of KOLs focused on clinical management of conditions in company’s therapeutic areas of interest; • Identify new KOL/HCPs for future engagement, including but not limited to identification of new clinical researcher, scientific advisors, and medical educators; • Collect medical insights and intelligence gathered from scientific exchange with clinical investigators and non-investigator thought leaders; • Attend and support key Medical/Scientific meetings to make contacts, evaluate the field and obtain ideas for improvements in trial design and conduct, trial awareness and patient recruitment/retention initiatives; • As required support Therapeutic Area Scientific/Clinical National and Regional Advisory Board meetings; • In collaboration with the Director patient advocacy and Sr Director Medical Affairs and Therapeutic Area Lead support Patient Advocacy initiatives in alignment with program and product strategies; • Cross-functionally identity feasibility and interest of investigators interested in Investigator Initiated Studies (IIS) in alignment with the asset and pipeline.